Sleep disturbances in Alzheimer's and Parkinson's diseases.

Neuromolecular Medicine
Sarah M Rothman, Mark P Mattson

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative disorders and exact a burden on our society greater than cardiovascular disease and cancer combined. While cognitive and motor symptoms are used to define AD and PD, respectively, patients with both disorders exhibit sleep disturbances including insomnia, hypersomnia and excessive daytime napping. The molecular basis of perturbed sleep in AD and PD may involve damage to hypothalamic and brainstem nuclei that control sleep-wake cycles. Perturbations in neurotransmitter and hormone signaling (e.g., serotonin, norepinephrine and melatonin) and the neurotrophic factor BDNF likely contribute to the disease process. Abnormal accumulations of neurotoxic forms of amyloid β-peptide, tau and α-synuclein occur in brain regions involved in the regulation of sleep in AD and PD patients, and are sufficient to cause sleep disturbances in animal models of these neurodegenerative disorders. Disturbed regulation of sleep often occurs early in the course of AD and PD, and may contribute to the cognitive and motor symptoms. Treatments that target signaling pathways that control sleep have been shown to retard the disease process in animal models of AD a...Continue Reading

References

Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·S A FactorW J Weiner
Jul 1, 1990·Journal of Gerontology·M V VitielloR K Ries
Feb 1, 1989·Biological Psychiatry·D L BliwiseW C Dement
Dec 1, 1988·Clinical Neuropharmacology·A J LeesV L Campbell
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E C HirschF Javoy-Agid
Sep 24, 1993·Annals of the New York Academy of Sciences·R Y Moore
Jan 1, 1993·Journal of Neural Transmission. General Section·A M Palmer, S T DeKosky
Jul 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·H P Kremer, G T Bots
Aug 15, 1996·Biological Psychiatry·E J van SomerenD F Swaab
Mar 21, 1997·Biological Psychology·T W Robbins
Oct 6, 1998·Archives of Internal Medicine·D L SherrillS F Quan
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergK Karlsen
Sep 14, 1999·Journal of Geriatric Psychiatry and Neurology·S M McCurryE B Larson
May 1, 2001·The American Journal of Psychiatry·L VolicerA Satlin
Jul 19, 2001·Brain : a Journal of Neurology·A D BaddeleyG K Wilcock
Aug 3, 2002·Nature Reviews. Neuroscience·Edward F Pace-Schott, J Allan Hobson
Aug 8, 2002·Archives of Neurology·Jose A LuchsingerRichard Mayeux
Sep 5, 2002·Nature Reviews. Neuroscience·J Allan Hobson, Edward F Pace-Schott
Dec 20, 2002·Journal of Geriatric Psychiatry and Neurology·R Scott Turner
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Jan 25, 2003·Experimental Gerontology·Debra J Skene, Dick F Swaab
Feb 14, 2003·Current Neurology and Neuroscience Reports·Cynthia L Comella
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Jay A Gingrich
Jun 18, 2003·The Journal of Comparative Neurology·Dwight C GermanChang-Lin Liang
Aug 29, 2003·The Journal of Pharmacology and Experimental Therapeutics·Stuart O Isaac, Craig W Berridge
Sep 16, 2003·International Journal of Geriatric Psychiatry·Ezio Giacobini
Oct 17, 2003·Respiratory Medicine·Basta MariaSiafakas M Nikolaos
Jun 11, 2004·Science of Aging Knowledge Environment : SAGE KE·Dietmar Rudolf ThalHeiko Braak
Sep 18, 2004·Trends in Neurosciences·Mark P MattsonBronwen Martin
Sep 24, 2004·Progress in Neurobiology·Jeremy K Seamans, Charles R Yang
Dec 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Navin MaswoodDonald K Ingram
Jan 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shinong WangRaimund Hirschberg

❮ Previous
Next ❯

Citations

Jul 17, 2013·International Journal of Molecular Sciences·Li LinQing Tian
Jun 3, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Monika TalarowskaPiotr Gałecki
Sep 11, 2014·International Journal of Molecular Sciences·Moshe Laudon, Anat Frydman-Marom
Aug 10, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Wei ZhangTong Zhang
Oct 9, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·R ManniC Zucchella
May 29, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Piotr GałeckiMichael Maes
May 10, 2015·Zeitschrift für Gerontologie und Geriatrie·E Savaskan
Sep 25, 2014·Frontiers in Endocrinology·Naoyuki Sato, Ryuichi Morishita
Sep 19, 2014·Lancet Neurology·Kristine YaffeTina Hoang
Mar 22, 2013·Therapeutic Advances in Endocrinology and Metabolism·Ifigenia Kostoglou-Athanassiou
Jul 31, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O V YakovlevaE A Lyashenko
Nov 22, 2018·Nature Reviews. Neuroscience·Ryan W Logan, Colleen A McClung
May 2, 2018·Current Medicinal Chemistry·Chit TamTao Zuo
Jul 4, 2020·Journal of Hypertension·Sang-Won YooJoong-Seok Kim
Aug 28, 2020·Acta Physiologica·Anna-Marie Finger, Achim Kramer
Dec 25, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Sang-Won YooJoong-Seok Kim
May 24, 2020·Journal of Parkinson's Disease·Daniel J van WamelenK Ray Chaudhuri
Oct 16, 2018·Journal of Alzheimer's Disease : JAD·Susanna C Larsson, Alicja Wolk
Sep 6, 2020·Journal of Hypertension·Sang-Won YooJoong-Seok Kim
Mar 27, 2015·Journal of Sleep Research·Jin-Cherng ChenJuen-Haur Hwang
Jan 1, 2015·Dementia & Neuropsychologia·Christianne Martins Corrêa da Silva Bahia, João Santos Pereira
Nov 26, 2016·Journal of Alzheimer's Disease : JAD·Annachiara CagninSara Montagnese
Sep 19, 2018·Journal of Alzheimer's Disease : JAD·Alexander J EhrenbergLea T Grinberg
Jun 17, 2020·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Alessandra CaporaleFelix W Wehrli
Aug 6, 2019·Frontiers in Endocrinology·Daniel P Cardinali
Dec 9, 2020·International Journal of Environmental Research and Public Health·Sergio Garbarino
Apr 4, 2020·Neurobiology of Disease·Adeel A MemonAmy W Amara
May 30, 2020·Current Biology : CB·Sarah D BenthemAaron A Wilber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.